1381P Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer (EC/GEJC) following neoadjuvant chemoradiotherapy (CRT): 14-month follow-up of CheckMate 577
Autor: | Moehler, M., Ajani, J.A., Kuzdzal, J., Zander, T., Van Cutsem, E., Piessen, G., Mendez, G., Feliciano, J., Motoyama, S., Lièvre, A., Uronis, H., Elimova, E., Grootscholten, C., Geboes, K., Zhang, J., Soleymani, S., Lei, M., Kondo, K., Cleary, J., Kelly, R.J. |
---|---|
Zdroj: | In Annals of Oncology September 2021 32 Supplement 5:S1045-S1046 |
Databáze: | ScienceDirect |
Externí odkaz: |